Bimatoprost Ophthalmic Solution and Eye

Bimatoprost Ophthalmic solution is a prescription drug treatment that has been established for the treatment of patients with glaucoma. In the clinical trials, its ability to stimulate eyelash hypertrichosis was noted as an adverse effect. Because of the beneficial application of the adverse effect, the ophthalmic preparation was branded for cosmetic purposes. One of the popularly known brands for eyelash growth is Careprost. Bimatoprost ophthalmic solution is a clinically approved prescription treatment for glaucoma and eyelash growth.

Bimatoprost for eyelash growth

Almost all women want denser and more prominent eyelashes. To achieve them, many visit their cosmetologist and many use mascara or fake eyelashes to get the prominent look. Eyes are considered as the feature that contributes the most to facial beauty. s

The result of a clinical trial showed that the active pharmaceutical ingredient causes the improved growth of eyelashes. The formula enhances the length and density of eyelashes. Unfortunately, not all women are blessed with long and luscious eyelashes.  Women with sparse or thin eyelashes or women who lost their most of the eye strands to disease experience considerable psychological distress. Eyelashes not only add beauty but also protect your eyes from dirt and dust. Out of several methods to enhance eyelashes, some are cosmetic and temporary such as the use of fake eyelashes and mascara. On the other hand, there are permanent techniques which use hair transplant techniques and are extremely painful and complicated. One of the easiest ways to improve the appearance of eyelashes is Bimatoprost Careprost. The foods and Drug Administration of USA approved Bimatoprost eye solution for use in patients suffering from sparse eyelashes.

The ophthalmic formulation reported success in stimulating fuller eyelash growth. The active constituent is a prostamide analogue. Prostaglandin receptors are present in the dermal papilla and the outer root sheath of the hair follicle. These receptors are believed to be involved in the development and regrowth of hair follicles. Research studies have demonstrated that the application of Bimatoprost changes the eyelash cycle by prolonging the resting (anagen) phase. Although the mode of action of Bimatoprost is still not known, it is considered safe and effective in multiple repeatable clinical trials.

Bimatoprost for glaucoma patients

Glaucoma is a leading cause of blindness. The eye condition can result in the damage to the optic nerve that carries information from the brain to the eye. A patient suffering from glaucoma has raised the fluid pressure within the eye. s

Bimatoprost is the most common treatment to lower high eye pressure, which is an important treatable risk factor in patients suffering from glaucoma. The Ophthalmic formulation is for people who have a specific type of glaucoma known as open-angle glaucoma or for people who have an eye condition called ocular hypertension.

Conclusion

The effectiveness of Careprost Bimatoprost is clinically approved in the improving the growth of eyelashes as well as improving the health of glaucoma patients. Studies performed to test its effectiveness and safety showed benefits on all counts of eyelash growth and lowering intraocular pressure in the eye. The lengthening of eyelashes is found due to the increase in the number of hairs in the resting stage of the hair follicle cycle of eyelashes. This effect of eyelash growth was initially found by chance when it was used to reduce eye pressure in glaucoma patients.

With Bimatoprost, many women wishing to improve the appearance of eyelashes can have longer, thicker, and darker eyelashes. The ophthalmic solution is a safe and effective cure for glaucoma.